The IMLFF chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the IMLFF chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The IMLFF stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View IMLFF Detailed Price Forecast - CNN Money||View IMLFF Detailed Summary - Google Finance|
|View IMLFF Detailed Summary - Yahoo! Finance||View IMLFF Stock Research & Analysis - Zacks.com|
|View IMLFF Trends & Analysis - Trade-Ideas||View IMLFF Major Holders - Barrons|
|View IMLFF Call Transcripts - NASDAQ||View IMLFF Breaking News & Analysis - Seeking Alpha|
|View IMLFF Annual Report - CompanySpotlight.com||View IMLFF OTC Short Report - OTCShortReport.com|
|View IMLFF Fundamentals - TradeKing||View IMLFF SEC Filings - Bar Chart|
|View Historical Prices for IMLFF - The WSJ||View Performance/Total Return for IMLFF - Morningstar|
|View the Analyst Estimates for IMLFF - MarketWatch||View the Earnings History for IMLFF - CNBC|
|View the IMLFF Earnings - StockMarketWatch||View IMLFF Buy or Sell Recommendations - MacroAxis|
|View the IMLFF Bullish Patterns - American Bulls||View IMLFF Short Pain Metrics - ShortPainBot.com|
|View IMLFF Stock Mentions - StockTwits||View IMLFF Stock Mentions - PennyStockTweets|
|View IMLFF Stock Mentions - Twitter||View IMLFF Investment Forum News - Investor Hub|
|View IMLFF Stock Mentions - Yahoo! Message Board||View IMLFF Stock Mentions - Seeking Alpha|
|View Insider Transactions for IMLFF - SECform4.com||View Insider Transactions for IMLFF - Insider Cow|
|View IMLFF Major Holdings Summary - CNBC||View Insider Disclosure for IMLFF - OTC Markets|
|View Insider Transactions for IMLFF - Yahoo! Finance||View Institutional Holdings for IMLFF - NASDAQ|
|View IMLFF Stock Insight & Charts - FinViz.com||View IMLFF Investment Charts - StockCharts.com|
|View IMLFF Stock Overview & Charts - BarChart||View IMLFF User Generated Charts - Trading View|
InMed Continues to Strengthen IP Portfolio for its Biosynthesis Platform Technology
Posted on Monday March 18, 2019
OTCQX:IMLFF), a biopharmaceutical company developing a proprietary biosynthesis platform technology for the manufacturing of pharmaceutical-grade cannabinoids as well as an R&D pipeline of medications targeting diseases with high unmet medical needs, today announced the publication of the first in a series of pending patent applications directed to the Company's biosynthesis platform technology for the manufacturing of pharmaceutical-grade cannabinoids.
These Four Marijuana Stocks May Surge On Friday
Posted on Friday March 15, 2019
CORAL GABLES, FL / ACCESSWIRE / March 15, 2019 / The marijuana stock market is constantly evolving as a result of the world slowly gaining a better understanding of the benefits of supporting the global cannabis industry. According to recent statistics, the global legal marijuana market is projected to reach $146.4 billion by the end of 2025. Legal cannabis has gained traction on a global scale due to the fact that consumers are pushing legislators to advocate for legislation in support of marijuana legalization.
OTC Markets Group Announces Gold Sponsorship of 31st Annual ROTH Conference
Posted on Wednesday March 13, 2019
OTCQX and OTCQB Companies Featured at 2019 ROTH Conference NEW YORK , March 13, 2019 /PRNewswire/ -- OTC Markets Group Inc . (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, ...
OTCQX:IMLFF), a biopharmaceutical company developing a proprietary biosynthesis platform technology for the manufacturing of pharmaceutical-grade cannabinoids as well as a R&D pipeline of medications targeting diseases with high unmet medical needs, today provided an update on its drug development program for the treatment of Epidermolysis Bullosa ("EB").